CClinicalTrials.gg
CompletedNCT05394038My-ABCDEUpdated May 27, 2022

Rapid Diagnosis of Patients With Chest Pain During the Covid-19 Outbreak (My-ABCDE)

An observational study in Chest Pain, sponsored by Shanghai 10th People's Hospital. Completed at 1 site in China. Open to participants aged 14 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-27.

Sponsored by Shanghai 10th People's Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
2,218
Ages
14 Years and older
Sex
All
01

Study summary

During the outbreak of COVID-19, among patients with chest tightness and chest pain as the main symptoms in major medical institutions in Shanghai, China, the past medical history and rapid testing were used to quickly identify the risk stratification of the patients.

Read the detailed description

During the outbreak of COVID-19, among patients with chest tightness and chest pain as the main symptoms in major medical institutions in Shanghai, China, the past medical history and rapid testing were used to quickly identify the risk stratification of the patients. Past medical history collection includes diabetes, hypertension, coronary atherosclerotic heart disease, percutaneous coronary stent implantation, etc. Rapid detection includes rapid myocardial markers, coagulation function, electrocardiogram, chest CT, etc. Risk stratification in the shortest possible time to reduce the time patients spend congregating in hospitals and reduce unnecessary contact to reduce the risk of Covid-19 infection.

02

Conditions studied

  • Chest Pain

Browse trials for

03

In context

Chest Pain

381 studies on the registry are indexed under Chest Pain; 66 are open to participants now.

This study's enrollment of 2,218 is above the median of 500 across 163 observational studies indexed under Chest Pain.

Browse Chest Pain studies →

Lead sponsor

Shanghai 10th People's Hospital is the lead sponsor of 167 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All patients who came to the hospital with chest tightness and chest pain during Covid-19.

Inclusion criteria

  • All patients who came to the hospital with chest tightness and chest pain during Covid-19.

Exclusion criteria

Exclusion Criteria:

  • None.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
2,218 participants (actual)
Patient registry
No

Groups and cohorts

  • CPC Cohort

    A patient with chest tightness and pain during the Covid-19 outbreak.

    Other: None,observational study.

Interventions

  • OtherNone,observational study.

    observational study

06

What researchers measure

Primary outcomes

  1. Diagnosis time

    The time from the first medical contact to the time of diagnosis.

    Time frame: 1 week

Secondary outcomes

  1. Diagnostic accuracy

    Preliminary and confirmed diagnoses were the same proportion of the total number of patients.

    Time frame: 1week

07

Study locations

1 site
  • Shanghai Tenth People's Hospital
    Shanghai, Shanghai 200072, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05394038
Lead sponsor
Shanghai 10th People's Hospital
Responsible party
Ya-Wei Xu (Director, Director of Cardiovascular Medicine, Shanghai 10th People's Hospital) — Principal investigator
First posted
May 27, 2022
Start date
May 1, 2022
Primary completion
May 20, 2022
Completion
May 20, 2022
Last update
May 27, 2022

Study contacts

Yawei Xu, PhD
study chair · Tongji University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion